ArticleDrugs - real world outcomes2026

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.

Vincenzo Mangialardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.